Where Am I? -> ABOUT US -> Publications -> Collaborative (By Subject) -> Prevention & Risk Factors - General
Direct link to this page: http://www.eurocat-network.eu/ABOUTUS/Publications/Collaborative(BySubject)/PreventionAndRiskFactors-General

 
Prevention & Risk Factors - General


Dolk H, Armstrong B, Lachowycz K, Vrijheid M, Rankin J, Abramsky L, Boyd P, Wellesley D (in press), "Ambient Air Pollution and Risk of Congenital Anomalies in England, 1991-99", Occupational and Environmental Medicine [doi: 10.1136/oem.2009.045997].  [Abstract]

EUGLOREH 2007 (2009), "The Status of Health in the European Union: Towards a Healthier Europe", EU Public Health Programme Project, Global Report on the Health Status in the European Union, Chapter 9.1.2  [http://www.eugloreh.it/ActionPagina_993.do]

EUROCAT (2009), "What is the "Primary" Prevention of Congneital Anomalies?", The Lancet, Vol 372, pp 378.  [Full Text]

Garne E, de Walle H (2009), "Letters to the Editor: Parental Age and Congenital Malformations", Paediatric & Perinatal Epidemiology, Vol 23, pp 279.  [Full Text]

Loane M, Dolk H, Morris JK and a EUROCAT Working Group (2009), "Maternal Age-Specific Risk of Non-Chromosomal Anomalies", British Journal of Gynaecology, Vol 116, pp 1111-1119.  [Full Text]

Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LTW and the EUROCAT Antiepileptic Drug Working Group (2008), "Does Lamotrigine Use in Pregnancy Increase Orofacial Cleft Risk Relative to Other Malformations", Neurology, Vol 71, pp 714-722.  [Abstract]


Abramsky L, Dolk H and a EUROCAT Folic Acid Working Group (2007)
, "Should Europe Fortify a Staple Food with Folic Acid?", The Lancet, Vol 369, pp 641-642.  [Abstract]

Dolk H (2007), "EUROCAT: Surveillance of Environmental Impact", Nicolopoulou-Stamati et al (Eds), Congenital Diseases and the Environment, pp 131-145.

Loane M, Dolk H, Bradbury and a EUROCAT Working Group (2007), "Increasing Prevalence of Gastroschisis in Europe 1980-2002: A Phenomenon Restricted to Younger Mothers?", Paediatric and Perinatal Epidemiology, Vol 21, pp 363-369.  [Abstract]


Botto LD, Lisi A, Bower C, Canfield MA, Dattani N, de Vigan C, de Walle H, Erickson EJ, Halliday J, Irgens LM, Lowry RB, McDonnell R, Metneki J, Poetzsch S, Ritvanen A, Robert-Gnansia E, Siffel C, Stoll C and Mastroiacovo P
(2006), "Trends of Selected Malformations in Relation to Folic Acid Recommendations and Fortification: An International Assessment", Birth Defects Research (Part A), Vol 76, pp 693-705.  [Abstract]

Dobson R (2006), "Rise in Maternal Age has Led to Increase in Pregnancies Affected by Down's Syndrome", BMJ, Vol 332, pp 1234.  [Full Text]

Meijer W, Cornel MC, Dolk H, de Walle HEK, Armstrong NC, de Jong-van den Berg LTW and a EUROCAT Working Group (2006), "The Potential of the European Network on Congenital Anomaly Registers (EUROCAT) for Drug Safety Surveillance: A Descriptive Study", Pharmacoepdemiology and Drug Safety, Vol 15, pp 675-682.  [Abstract]


Abramsky L, Busby A, Dolk H (2005), "Promotion of Perinconceptional Folic Acid has had Limited Success", Journal of the Royal Society for the Promotion of Health, Vol 125, No 5, pp 206-208.

Botto L, Lisi A, Robert-Gnansia E, Erickson J, Vollset S, Mastroiacovo P, Botting B, Cocchi G, de Vigan C, de Walle H, Feijoo M, Irgens L, McDonnell B, Merlob P, Ritvanen A, Scaran G, Siffel C, Metneki J, Stoll C, Smithells R, Goujard J (2005), "International Retrospective Cohort Study of Neural Tube Defects in Relation to Folic Acid Recommendations: Are the Recommendations Working?" BMJ Online First bmj.com.

Busby A, Armstrong B, Dolk H, Armstrong N, Haeusler M, Berghold A, Gillerot Y, Baguette A, Gjergja R, Barisic I, Christiansen M, Goujard J, Steinbicker V, Roesch C, McDonnell R, Scarano G, Calzolari E, Neville A, Cocchi G, Bianca S, Gatt M, de Walle H, Braz P, Latos-Bielenska A, Gener B, Portillo I, Addor M-C, Abramsky L, Ritvanen A, Robert-Gnansia E, Daltveit, A, Aneren G, Ollars B, Edwards G (2005), "Preventing Neural Tube Defects in Europe: A Missed Opportunity", Reproductive Toxicology, Vol 20, No 3, pp 393-402. 

Busby A, Abramsky L, Dolk H, Armstrong B and a EUROCAT Folic Acid Working Group (2005), "Preventing Neural Tube Defects in Europe: Population Based Study", British Medical Journal, Vol 330, pp 574-575.

Busby A, Armstrong B, Dolk H (2005), "Eye Anomalies: Seasonal Variation and Maternal Viral Infections", Epidemiology, Vol 16, No 3, pp 317-322.

Dolk H (2005), "Strategies for Prevention", European Conference on Rare Diseases, Luxembourg 21-22 June, pp 165-167.

EUROCAT (2005), "EUROCAT Special Report: Prevention of Neural Tube Defects by Periconceptional Folic Acid Supplementation in Europe", 2nd Edition, EUROCAT Central Registry, University of Ulster. [Report], [Country Chapters Austria to Ireland], [Country Chapters Italy to UK], [Appendices I and II], [Appendix III]

Morris JK, de Vigan C, Mutton DE, Alberman E (2005), "Risk of a Down Syndrome Live Birth in Women of 45 Years of Age and Older", Prenatal Diagnosis, Vol 25, pp 275-278. 


Nieuwenhuijsen MJ, Toledano MB, Bennett J, Best N, Hambly P, de Hoogh C, Wellesley D, Boyd PA, Abramsky L, Dattani N, Fawell J, Briggs D, Jarup L, Elliott P (2008) "Chlorination Disinfection By-Products and Risk of Congenital Anomalies in England and Wales", Environmental Health Perspectives, Vol 116, No 2, pp 216-222.  [Full Text]

Dolk H, Loane M (2004), "Impact of Multiple Births on the Prevalence of Congenital Anomalies in Europe", IEA/EEF Abstracts, Journal of Epidemiology & Community Health, Vol 58, Suppl 1, pp A18.

EUROCAT
(2004)  "EUROCAT Special Report: A Review of Environmental Risk Factors for Congenital Anomalies", EUROCAT Central Registry, University of Ulster, ISBN 1-85923-187-X. [Table of Contents], [Parts 1 and 2], [Part 3], Updates: [Obesity, October 2004], [Testing for Teratogenicity, March 2007]

EUROCAT
(2004), "7th European Symposium on the Prevention of Congenital Anomalies, 30 May 2003, Heidelberg, Germany", Conference Programme, Reproductive Toxicology, Vol 18, pp 135-156.

EUROCAT (2003), "A Study of the Geographical Variation in Overall Rates of Congenital Abnormalities and the Rates of Specific Abnormalities", EUROCAT Central Registry, University of Ulster.

Abramsky L, Addor M, Armstrong N, Barisic I, Berghold A, Braz P, Calzolari E, Christiansen M, Cocchi G, Daltveit A, de Walle H, Dolk H, Edwards G, Gatt M, Gener B, Gillerot Y, Gjergia R, Goujard J, Haeusler M, Latos-Bielenska A, McDonnell B, Neville A, Ritvanen A, Rosato M, Rosch C & Steinbicker V (2002)  Folic Acid Supplementation in Europe: A EUROCAT Report.  Reproductive Toxicology, 16, 435-436

Dolk H, McElhatton P (2002)  Assessing epidemiological evidence for the teratogenic effects of anticonvulsant medications.  Journal of Medical Genetics, 39, 243-244

EUROCAT (2002), "EUROCAT Special Report: Risk of Congenital Anomaly in Relation to Residence Near Hazardous Waste Landfill Sites", EUROCAT Central Registry, University of Ulster and London School of Hygiene & Tropical Medicine, pp 1-236.

Van Tongeren M, Nieuwenhuijsen M, Gardiner K, Armstrong B, Vrijheid M, Dolk H & Botting B  (2002)  A job exposure matrix for potential endocrine disrupting chemicals developed for a study into the association between maternal occupational exposure and hypospadias. Annals of Occupational Hygiene, 46, 5, 465-477

Vrijheid M, Armstrong B, Dolk H, van Tongeren M, Botting B (2002), "Risk of Hypospadias in Relation to Maternal Occupational Exposure to Endocrine Disrupting Chemicals", Occup Med Child Neurol, Vol 60, pp 543-550.